To determine the importance of nutritional status, social status, and inflammatory status in the prognosis of head and neck cancer.
Study Design
Single-center retrospective study of prospectively collected data.
Setting
Tertiary referral center.
Methods
Ninety-two consecutive patients newly diagnosed for cancer of the upper aerodigestive tract without metastases were assessed at time of diagnosis for several prognostic factors. Nutritional status was assessed by the nutritional risk index, social status by the EPICES score, and inflammatory status by the systemic inflammatory response index. The primary endpoint was overall survival.
Results
In multivariable analysis, the main prognostic factors were the TNM classification (hazard ratio [HR] = 3.34, P = .002, for stage T3-4), malnutrition as assessed by the nutritional risk index (HR = 3.64, P = .008, for severe malnutrition), and a systemic inflammatory response index score ≥1.6 (HR = 3.32, P = .02). Social deprivation was not a prognostic factor.
Conclusion
Prognosis in head and neck cancer is multifactorial; however, malnutrition and inflammation are important factors that are potentially reversible by early intervention.
PfisterDGAngKKBrizelDM, et al. Head and neck cancers: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2011;9:596-650.
2.
National Cancer Intelligence Network. Cancer by Deprivation in England: Incidence, 1996-2010; Mortality, 1997-2011. Public Health England;2011.
3.
DantasTSDe Barros SilvaPGSousaEF, et al. Influence of educational level, stage, and histological type on survival of oral cancer in a Brazilian population: a retrospective study of 10 years observation. Medicine (Baltimore). 2016;95(3):e2314. doi:10.1097/MD.0000000000002314
4.
LiuFChenFHuangJ, et al. Prospective study on factors affecting the prognosis of oral cancer in a Chinese population. Oncotarget. 2017;8:4352-4359.
5.
LabbeEBlanquetMGerbaudL, et al. A new reliable index to measure individual deprivation: the EPICES score. Eur J Public Health. 2015;25:604-609.
6.
WoolleyEMagennisPShokarP, et al. The correlation between indices of deprivation and health-related quality of life in patients with oral and oropharyngeal squamous cell carcinoma. Br J Oral Maxillofac Surg. 2006;44:177-186.
7.
NahonSLahmekPMacaigneG, et al. Socioeconomic deprivation does not influence the severity of Crohn’s disease: results of a prospective multicancer study. Inflammatory Bowel Diseases. 2009;15:594-598.
8.
ConversMLangeronASassC, et al. Intérêt de l’échelle d’évaluation de la précarité EPICES en obstétrique. Gynecologie Obstetrique et Fertilite. 2012;40:208-212.
9.
BihanHRamentolMFysekidisM, et al. Screening for deprivation using the EPICES score: a tool for detecting patients at high risk of diabetic complications and poor quality of life. Diabetes Metab. 2012;38:82-85.
10.
QuenotJ-PHelmsJLabroG, et al. Influence of deprivation on initial severity and prognosis of patients admitted to the ICU: the prospective, multicentre, observational IVOIRE cohort study. Ann Intensive Care. 2020;10:20.
11.
SaroulNPastourelRMulliezA, et al. Which assessment method of malnutrition in head and neck cancer?Otolaryngol Head Neck Surg. 2018;158:1065-1071.
12.
BaoXLiuFLinJ, et al. Nutritional assessment and prognosis of oral cancer patients: a large-scale prospective study. BMC Cancer. 2020;20(1):146. doi:10.1186/s12885-020-6604-2
13.
WongAZhuDKrausD, et al. Radiologically defined sarcopenia affects survival in head and neck cancer: a meta-analysis. Laryngoscope. Published online March27, 2020. doi:10.1002/lary.28616
14.
MagnanoMMolaPMachettaG, et al. The nutritional assessment of head and neck cancer patients. Eur Arch Otorhinolaryngol. 2014;272:3793-3799.
15.
DiakosCICharlesKAMcMillanDC, et al. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493-e503.
16.
YeJLiaoBJiangX, et al. Prognosis value of platelet counts, albumin and neutrophil-lymphocyte ratio of locoregional recurrence in patients with operable head and neck squamous cell carcinoma. Cancer Manag Res. 2020;12:731-741.
17.
Shoultz-HenleySGardenASMohamedASR, et al. Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation. Int J Cancer. 2016;138:1290-1297.
18.
ZhangHShangXRenP, et al. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. J Cell Physiol. 2019;234:1794-1802.
19.
ThamTOlsonCKhaymovichJ, et al. The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2018;275:1663-1670.
20.
BardashYOlsonCHermanW, et al. Platelet-lymphocyte ratio as a predictor of prognosis in head and neck cancer: a systematic review and meta-analysis. Oncol Res Treat. 2019;42:665-676.
21.
TakenakaYOyaRKitamiuraT, et al. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: a meta-analysis. Head Neck. 2018;40:647-655.
22.
GengYZhuDWuC, et al. A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. Int Immunopharmacol. 2018;65:503-510.
23.
ValeroCPardoLSansaA, et al. Prognostic capacity of systemic inflammation response index (SIRI) in patients with head and neck squamous cell carcinoma. Head Neck. 2020;42:336-343.
24.
ChenYJiangWXiD, et al. Development and validation of nomogram based on SIRI for predicting the clinical outcome in patients with nasopharyngeal carcinomas. J Investig Med. 2019;67:691-698.
25.
ChenZWangKLuH, et al. Systemic inflammation response index predicts prognosis in patients with clear cell renal cell carcinoma: a propensity score–matched analysis. Cancer Manag Res. 2019;11:909-919.
26.
SassCGuéguenRMoulinJJ, et al. Comparaison du score individuel de précarité des Centres d’examens de santé, EPICES, à la définition socio-administrative de la précarité. Sante Publique. 2006;18:513-522.
27.
RighiniCATimiNJunetP, et al. Assessment of nutritional status at the time of diagnosis in patients treated for head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis. 2013;130:8-14.
28.
AngKKHarrisJWheelerR, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24-35.
29.
CaburetCFarigonNMulliezA, et al. Impact of nutritional status at the outset of assessment on postoperative complications in head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137(5):393-398. doi:10.1016/j.anorl.2019.12.005
30.
WillemsenACHHoebenALalisangRI, et al. Disease-induced and treatment-induced alterations in body composition in locally advanced head and neck squamous cell carcinoma. J Cachexia Sarcopenia Muscle. 2020;11:145-159.
31.
GhadjarPHayozSZimmermannF, et al. Impact of weight loss on survival after chemoradiation for locally advanced head and neck cancer: secondary results of a randomized phase III trial (SAKK 10/94). Radiat Oncol. 2015;10:21. doi:10.1186/s13014-014-0319-y
32.
GrossbergAJChamchodSFullerCD, et al. Association of body composition with survival and locoregional control of radiotherapy-treated head and neck squamous cell carcinoma. JAMA Oncol. 2016;2:782-789.
33.
LangiusJAEBakkerSRietveldDHF, et al. Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy. Br J Cancer. 2013;109:1093-1099.
34.
NishikawaDHanaiNSuzukiH, et al. The impact of skeletal muscle depletion on head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec. 2018;80:1-9.
35.
DatemaFRFerrierMBBaatenburg De JongRJ. Impact of severe malnutrition on short-term mortality and overall survival in head and neck cancer. Oral Oncology. 2011;47:910-914.
36.
FearonKStrasserFAnkerSD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489-495.
37.
NakayamaMTabuchiKHaraA. Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer. Head and Neck. 2015;37:1745-1749.
38.
NakayamaMGoshoMAdachiM, et al. The geriatric nutritional risk index as a prognostic factor in patients with advanced head and neck cancer. Laryngoscope. Published online February21, 2020. doi:10.1002/lary.28587
39.
ArendsJBachmannPBaracosV, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36:11-48.
40.
BoisselierPKaminskyM-CThézenasS, et al. A double-blind phase III trial of immunomodulating nutritional formula during adjuvant chemoradiotherapy in head and neck cancer patients: IMPATOX. Am J Clin Nutr. Published online September16, 2020. doi:10.1093/ajcn/nqaa227
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
